首页 > 最新文献

Gastroenterology and Hepatology From Bed to Bench最新文献

英文 中文
Investigating the effects of vitamin D3 and 5-aminosalicylic acid (Mesalazine) on the expression of virulence determinants in Escherichia coli isolated from patients with IBD and colorectal cancer. 研究维生素D3和5-氨基水杨酸(美沙拉嗪)对IBD和结直肠癌患者分离的大肠杆菌毒力决定因子表达的影响。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.22037/ghfbb.v18i2.3061
Seyed Abolfazl Hosseininasab, Fereshteh Saffari, Omid Tadjrobehkar, Hengameh Zandi, Bijan Ahmadi

Aim: Based on studies, E. coli strains producing colibactin are selectively enriched in patients with IBD and CRC. This finding raises the possibility that the mentioned compounds may affect this organism and prompted us to conduct this study.

Background: Currently, vitamin D3 is highly recommended in the therapeutic management of inflammatory bowel disease (IBD) and colorectal cancer (CRC). Similar to 5-Aminosalicylic acid (5-ASA) which is a mainstay in treatment of IBD and prevention of CRC related inflammation, the importance of vitamin D3 is also mainly attributed to a series of known protective effects of this compound, particularly regulation of immune response and gut microbiota.

Methods: The antimicrobial effects of vitamin D3 and 5-ASA against E. coli isolated from patients with CRC, IBD, and healthy individuals were assessed by microdilution broth. The expression of virulence-associated genes (clbN, ompC, chuA and yfgL) in isolates treated with these compounds was tested by real-time PCR.

Results: Neither vitamin D3 nor 5-ASAinhibited bacterial growth at the investigated concentrations. The expression of clbN and ompC significantly decreased in vitamin D3-treated isolates (p= 0.01, p= 0.02, respectively). This downregulation was also significant in isolates from the CRC group in comparison with those from IBD patients and healthy individuals.

Conclusion: Vitamin D3's effect on downregulating colibactin, one of the proposed factors in colon carcinogenesis, highlights another unknown aspect of this multifaceted drug. The inability of both studied compounds to inhibit the growth of E. coli may show their benefit in not disturbing the balance of the microbiota.

目的:根据研究,产生大肠杆菌蛋白的大肠杆菌菌株在IBD和CRC患者中选择性富集。这一发现提高了上述化合物可能影响这种生物体的可能性,并促使我们进行这项研究。背景:目前,维生素D3被强烈推荐用于炎症性肠病(IBD)和结直肠癌(CRC)的治疗管理。与5-氨基水杨酸(5-ASA)类似,维生素D3的重要性也主要归因于该化合物的一系列已知保护作用,特别是对免疫反应和肠道微生物群的调节。5-氨基水杨酸是治疗IBD和预防CRC相关炎症的主要成分。方法:采用微量稀释肉汤法测定维生素D3和5-ASA对结直肠癌、IBD和健康人大肠杆菌的抑菌效果。用实时荧光定量PCR检测了这些化合物处理过的菌株中毒力相关基因(clbN、ompC、chuA和yfgL)的表达。结果:在研究浓度下,维生素D3和5- as3均未抑制细菌生长。维生素d3处理后,clbN和ompC的表达显著降低(p= 0.01, p= 0.02)。与来自IBD患者和健康个体的分离株相比,CRC组分离株的这种下调也很显著。结论:维生素D3对下调大肠杆菌蛋白(大肠杆菌蛋白是结肠癌发生的一个被提出的因素)的作用,突出了这种多面药物的另一个未知方面。所研究的两种化合物都不能抑制大肠杆菌的生长,这可能表明它们的好处是不会扰乱微生物群的平衡。
{"title":"Investigating the effects of vitamin D3 and 5-aminosalicylic acid (Mesalazine) on the expression of virulence determinants in <i>Escherichia coli</i> isolated from patients with IBD and colorectal cancer.","authors":"Seyed Abolfazl Hosseininasab, Fereshteh Saffari, Omid Tadjrobehkar, Hengameh Zandi, Bijan Ahmadi","doi":"10.22037/ghfbb.v18i2.3061","DOIUrl":"10.22037/ghfbb.v18i2.3061","url":null,"abstract":"<p><strong>Aim: </strong>Based on studies, <i>E. coli</i> strains producing colibactin are selectively enriched in patients with IBD and CRC. This finding raises the possibility that the mentioned compounds may affect this organism and prompted us to conduct this study.</p><p><strong>Background: </strong>Currently, vitamin D3 is highly recommended in the therapeutic management of inflammatory bowel disease (IBD) and colorectal cancer (CRC). Similar to 5-Aminosalicylic acid (5-ASA) which is a mainstay in treatment of IBD and prevention of CRC related inflammation, the importance of vitamin D3 is also mainly attributed to a series of known protective effects of this compound, particularly regulation of immune response and gut microbiota.</p><p><strong>Methods: </strong>The antimicrobial effects of vitamin D3 and 5-ASA against <i>E. coli</i> isolated from patients with CRC, IBD, and healthy individuals were assessed by microdilution broth. The expression of virulence-associated genes (<i>clbN</i>, <i>ompC</i>, <i>chuA</i> and <i>yfgL</i>) in isolates treated with these compounds was tested by real-time PCR.</p><p><strong>Results: </strong>Neither vitamin D3 nor 5-ASAinhibited bacterial growth at the investigated concentrations. The expression of <i>clbN</i> and <i>ompC</i> significantly decreased in vitamin D3-treated isolates (p= 0.01, p= 0.02, respectively). This downregulation was also significant in isolates from the CRC group in comparison with those from IBD patients and healthy individuals.</p><p><strong>Conclusion: </strong>Vitamin D3's effect on downregulating colibactin, one of the proposed factors in colon carcinogenesis, highlights another unknown aspect of this multifaceted drug. The inability of both studied compounds to inhibit the growth of <i>E. coli</i> may show their benefit in not disturbing the balance of the microbiota.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"18 2","pages":"252-259"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421929/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145039962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Seroprevalence of hepatitis E virus among solid organ transplant recipients: insights from southern Iran. 实体器官移植受者戊型肝炎病毒的血清患病率:来自伊朗南部的见解
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.22037/ghfbb.v18i2.3110
Zahra Amiri, Sahar Karami, Aboulfazl Gheshlaghi, Seyed Mohammad Ali Hashemi, Bahador Sarkari, Leila Morabbi, Jamal Sarvari

Aim: This study assessed the prevalence of anti-Hepatitis E Virus (HEV) IgG and IgM antibodies in Solid Organ Transplant (SOT) recipients in Fars Province, southern Iran.

Background: HEV is a common cause of viral hepatitis worldwide. Immunocompromised individuals, particularly SOT recipients, are at risk of chronic HEV infection.

Methods: In this cross-sectional study, 150 serum samples were collected from SOT recipients, including those with liver, kidney, intestinal, or simultaneous pancreas-kidney transplantation. The sera were stored at -20°C and analyzed for anti-HEV IgG and IgM, using a commercial ELISA kit. Data were analyzed, using SPSS.

Results: The mean age of participants was 46.24 ± 15.14 years; with 96 (64%) being male. Anti-HEV IgG antibodies were detected in 53 (35.3%) patients. The prevalence among liver and kidney recipient recipients was 33.3% and 39.2%, respectively (p = 0.63). Anti-HEV IgG seropositivity was significantly associated with older age (p < 0.001) and elevated blood urea nitrogen levels (p = 0.008). No significant associations were observed with other demographic or clinical variables (p > 0.05). All patients tested negative for anti-HEV IgM antibodies.

Conclusion: HEV exposure is relatively common among SOT recipients in southern Iran. The significant association with elevated blood urea nitrogen levels highlights the importance of renal function monitoring in this population.

目的:本研究评估了伊朗南部法尔斯省实体器官移植(SOT)受者中抗戊型肝炎病毒(HEV) IgG和IgM抗体的流行情况。背景:HEV是世界范围内病毒性肝炎的常见病因。免疫功能低下的个体,特别是SOT受体,有慢性HEV感染的危险。方法:在这项横断面研究中,收集了150份SOT受者的血清样本,包括肝、肾、肠或同时胰肾移植。将血清保存在-20°C,使用商用ELISA试剂盒检测抗hev IgG和IgM。数据分析采用SPSS统计软件。结果:参与者平均年龄46.24±15.14岁;其中96人(64%)是男性。53例(35.3%)患者检测到抗hev IgG抗体。肝受体和肾受体的患病率分别为33.3%和39.2% (p = 0.63)。抗hev IgG血清阳性与年龄(p < 0.001)和血尿素氮水平升高(p = 0.008)显著相关。与其他人口统计学或临床变量无显著相关性(p < 0.05)。所有患者抗hev IgM抗体检测均为阴性。结论:HEV暴露在伊朗南部SOT接受者中相对常见。与血尿素氮水平升高的显著关联突出了在这一人群中监测肾功能的重要性。
{"title":"Seroprevalence of hepatitis E virus among solid organ transplant recipients: insights from southern Iran.","authors":"Zahra Amiri, Sahar Karami, Aboulfazl Gheshlaghi, Seyed Mohammad Ali Hashemi, Bahador Sarkari, Leila Morabbi, Jamal Sarvari","doi":"10.22037/ghfbb.v18i2.3110","DOIUrl":"10.22037/ghfbb.v18i2.3110","url":null,"abstract":"<p><strong>Aim: </strong>This study assessed the prevalence of anti-Hepatitis E Virus (HEV) IgG and IgM antibodies in Solid Organ Transplant (SOT) recipients in Fars Province, southern Iran.</p><p><strong>Background: </strong>HEV is a common cause of viral hepatitis worldwide. Immunocompromised individuals, particularly SOT recipients, are at risk of chronic HEV infection.</p><p><strong>Methods: </strong>In this cross-sectional study, 150 serum samples were collected from SOT recipients, including those with liver, kidney, intestinal, or simultaneous pancreas-kidney transplantation. The sera were stored at -20°C and analyzed for anti-HEV IgG and IgM, using a commercial ELISA kit. Data were analyzed, using SPSS.</p><p><strong>Results: </strong>The mean age of participants was 46.24 ± 15.14 years; with 96 (64%) being male. Anti-HEV IgG antibodies were detected in 53 (35.3%) patients. The prevalence among liver and kidney recipient recipients was 33.3% and 39.2%, respectively (p = 0.63). Anti-HEV IgG seropositivity was significantly associated with older age (p < 0.001) and elevated blood urea nitrogen levels (p = 0.008). No significant associations were observed with other demographic or clinical variables (p > 0.05). All patients tested negative for anti-HEV IgM antibodies.</p><p><strong>Conclusion: </strong>HEV exposure is relatively common among SOT recipients in southern Iran. The significant association with elevated blood urea nitrogen levels highlights the importance of renal function monitoring in this population.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"18 2","pages":"205-210"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421930/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145039975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Translation and linguistic validation of the Persian version of the patient assessment of upper gastrointestinal symptom severity index and quality of life. 波斯语版患者上消化道症状严重程度指数及生活质量评估的翻译及语言验证。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.22037/ghfbb.v18i1.3036
Molood Alimirzaie, Mehran Rashidi, Hassan Shahoon, Tasnim Adibi, Narges Shahoon, Peyman Adibi

Aim: This study aimed to ascertain the equivalence in meaning and measurement qualities of two assessment tools, namely the Patient Assessment of Upper Gastrointestinal Symptom Severity Index (PAGI-SYM) and Quality of Life (PAGI-QOL), in a sample of individuals with upper gastrointestinal disorders in Iran.

Background: There is substantial demand for reliable and accurate research instruments in researchers' native language to evaluate specific concepts of interest.

Methods: The Rome Foundation Guideline was employed as a framework for this investigation. To this end, a rigorous translation process was utilized, involving forward translation by two independent translators, reconciliation, and backward translation. An expert committee evaluated the semantic, idiomatic, experiential, and conceptual aspects of the translations. A panel of gastroenterologists assessed the content and face validity of the translated questionnaires. Cognitive debriefing sessions were conducted involving patients with dyspepsia or gastroesophageal reflux disease. Concurrent validity of the questionnaires was ascertained by comparing them with the 36-item Short Form Health Survey (SF-36).

Results: The findings presented satisfactory translation of the assessment tools, with initial assessments of internal consistency and construct validity demonstrating suitability. In this particular sample, the internal consistency of the PAGI-SYM was excellent (Cronbach's α range: 0.62-0.92), while the PAGI-QOL indicated good internal consistency (Cronbach's α range: 0.68-0.95). Further, there were strong correlations between the total scores of PAGI-SYM and PAGI-QOL, as well as all SF-36 general health subscale (-0.469 and 0.572, p-value<0.001), demonstrating concurrent validity.

Conclusion: Both PAGI-QOL and PAGI-SYM instruments exhibited validity and reliability when applied to assess upper gastrointestinal disorders.

目的:本研究旨在确定两种评估工具,即患者上消化道症状严重程度指数评估(PAGI-SYM)和生活质量评估(PAGI-QOL)在伊朗上消化道疾病患者样本中的意义和测量质量的等效性。背景:研究人员对可靠和准确的母语研究工具有很大的需求,以评估感兴趣的特定概念。方法:采用罗马基金会指南作为本研究的框架。为此,采用了严格的翻译流程,包括由两名独立的译者进行前译、调和和后译。一个专家委员会评估了翻译的语义、习语、经验和概念方面。一组胃肠病学家评估了翻译后的问卷的内容和有效性。对患有消化不良或胃食管反流疾病的患者进行认知情况汇报。通过与36项健康问卷(SF-36)进行比较,确定问卷的同时效度。结果:评估工具的翻译结果令人满意,初步评估的内部一致性和结构效度证明了适用性。在该样本中,PAGI-SYM的内部一致性较好(Cronbach's α范围:0.62-0.92),PAGI-QOL的内部一致性较好(Cronbach's α范围:0.68-0.95)。此外,PAGI-SYM总分与PAGI-QOL总分以及SF-36一般健康量表之间存在较强的相关性(-0.469和0.572,p值)。结论:PAGI-QOL和PAGI-SYM量表在评估上消化道疾病时均具有良好的效度和信度。
{"title":"Translation and linguistic validation of the Persian version of the patient assessment of upper gastrointestinal symptom severity index and quality of life.","authors":"Molood Alimirzaie, Mehran Rashidi, Hassan Shahoon, Tasnim Adibi, Narges Shahoon, Peyman Adibi","doi":"10.22037/ghfbb.v18i1.3036","DOIUrl":"10.22037/ghfbb.v18i1.3036","url":null,"abstract":"<p><strong>Aim: </strong>This study aimed to ascertain the equivalence in meaning and measurement qualities of two assessment tools, namely the Patient Assessment of Upper Gastrointestinal Symptom Severity Index (PAGI-SYM) and Quality of Life (PAGI-QOL), in a sample of individuals with upper gastrointestinal disorders in Iran.</p><p><strong>Background: </strong>There is substantial demand for reliable and accurate research instruments in researchers' native language to evaluate specific concepts of interest.</p><p><strong>Methods: </strong>The Rome Foundation Guideline was employed as a framework for this investigation. To this end, a rigorous translation process was utilized, involving forward translation by two independent translators, reconciliation, and backward translation. An expert committee evaluated the semantic, idiomatic, experiential, and conceptual aspects of the translations. A panel of gastroenterologists assessed the content and face validity of the translated questionnaires. Cognitive debriefing sessions were conducted involving patients with dyspepsia or gastroesophageal reflux disease. Concurrent validity of the questionnaires was ascertained by comparing them with the 36-item Short Form Health Survey (SF-36).</p><p><strong>Results: </strong>The findings presented satisfactory translation of the assessment tools, with initial assessments of internal consistency and construct validity demonstrating suitability. In this particular sample, the internal consistency of the PAGI-SYM was excellent (Cronbach's α range: 0.62-0.92), while the PAGI-QOL indicated good internal consistency (Cronbach's α range: 0.68-0.95). Further, there were strong correlations between the total scores of PAGI-SYM and PAGI-QOL, as well as all SF-36 general health subscale (-0.469 and 0.572, p-value<0.001), demonstrating concurrent validity.</p><p><strong>Conclusion: </strong>Both PAGI-QOL and PAGI-SYM instruments exhibited validity and reliability when applied to assess upper gastrointestinal disorders.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"18 1","pages":"91-99"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12301542/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144741961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The epigenetic influence of diet-induced gut microbiome changes in precision nutrition - a systematic review. 精确营养中饮食诱导的肠道微生物组变化的表观遗传影响-系统综述。
Q3 Medicine Pub Date : 2025-01-01 Epub Date: 2025-08-26 DOI: 10.22037/ghfbb.v18i3.3136
Kolawole Yusuf Suleiman, Ganiu Jimoh Akorede, Basiru Afisu, Ali Olalekan Onimajesin, Aremu Saadudeen, Mariam Oluwakemi Lawal

Aim: This systematic review aimed to comprehensively evaluate the existing literature on the epigenetic influence of diet-induced gut microbiome changes in the context of precision nutrition.

Background: Diet influences gut microbiome composition, which regulates epigenetic modifications affecting inflammation, metabolism, and disease susceptibility. Precision nutrition seeks to personalize dietary strategies based on these interactions, yet the role of microbiome-driven epigenetic regulation remains under investigation.

Methods: A systematic review was conducted in 2025 following PRISMA guidelines. Studies exploring the relationship between dietary interventions, gut microbiome composition, and epigenetic changes were identified via PubMed and Google Scholar. Thirty-five studies, including randomized controlled trials, cohort studies, and observational research, met the inclusion criteria. Data on dietary interventions, microbial composition, epigenetic modifications, and health outcomes were synthesized.

Results: Diets rich in fiber and polyphenols enhanced microbial diversity, increased short-chain fatty acid production, and positively influenced epigenetic markers related to metabolic health. In contrast, Western-style and high-fat diets were associated with gut dysbiosis, inflammation, and negative epigenetic changes linked to metabolic disorders. Dietary interventions impacted DNA methylation, histone modifications, and microRNA expression, influencing long-term health.

Conclusion: This review highlights the key role of diet-induced changes in the gut microbiome in modulating epigenetic mechanisms like DNA methylation and histone modifications. These alterations influence metabolic health, disease risk, and precision nutrition strategies. While dietary interventions show promise, challenges such as individual variability and methodological inconsistencies require further research to refine clinical applications of microbiome-driven nutrition.

目的:本系统综述旨在全面评价在精确营养背景下饮食诱导肠道微生物组变化的表观遗传影响的现有文献。背景:饮食影响肠道微生物组成,调节影响炎症、代谢和疾病易感性的表观遗传修饰。精确营养寻求基于这些相互作用的个性化饮食策略,但微生物组驱动的表观遗传调控的作用仍在研究中。方法:根据PRISMA指南于2025年进行了系统评价。通过PubMed和谷歌Scholar确定了探索饮食干预、肠道微生物组组成和表观遗传变化之间关系的研究。包括随机对照试验、队列研究和观察性研究在内的35项研究符合纳入标准。综合了饮食干预、微生物组成、表观遗传修饰和健康结果的数据。结果:富含纤维和多酚的饮食增强了微生物多样性,增加了短链脂肪酸的产生,并积极影响与代谢健康相关的表观遗传标记。相反,西式饮食和高脂肪饮食与肠道生态失调、炎症和与代谢紊乱相关的负表观遗传变化有关。饮食干预影响DNA甲基化、组蛋白修饰和microRNA表达,影响长期健康。结论:本综述强调了饮食诱导的肠道微生物组变化在调节表观遗传机制(如DNA甲基化和组蛋白修饰)中的关键作用。这些改变影响代谢健康、疾病风险和精确营养策略。虽然饮食干预显示出希望,但个体差异和方法不一致等挑战需要进一步研究,以完善微生物组驱动营养的临床应用。
{"title":"The epigenetic influence of diet-induced gut microbiome changes in precision nutrition - a systematic review.","authors":"Kolawole Yusuf Suleiman, Ganiu Jimoh Akorede, Basiru Afisu, Ali Olalekan Onimajesin, Aremu Saadudeen, Mariam Oluwakemi Lawal","doi":"10.22037/ghfbb.v18i3.3136","DOIUrl":"10.22037/ghfbb.v18i3.3136","url":null,"abstract":"<p><strong>Aim: </strong>This systematic review aimed to comprehensively evaluate the existing literature on the epigenetic influence of diet-induced gut microbiome changes in the context of precision nutrition.</p><p><strong>Background: </strong>Diet influences gut microbiome composition, which regulates epigenetic modifications affecting inflammation, metabolism, and disease susceptibility. Precision nutrition seeks to personalize dietary strategies based on these interactions, yet the role of microbiome-driven epigenetic regulation remains under investigation.</p><p><strong>Methods: </strong>A systematic review was conducted in 2025 following PRISMA guidelines. Studies exploring the relationship between dietary interventions, gut microbiome composition, and epigenetic changes were identified via PubMed and Google Scholar. Thirty-five studies, including randomized controlled trials, cohort studies, and observational research, met the inclusion criteria. Data on dietary interventions, microbial composition, epigenetic modifications, and health outcomes were synthesized.</p><p><strong>Results: </strong>Diets rich in fiber and polyphenols enhanced microbial diversity, increased short-chain fatty acid production, and positively influenced epigenetic markers related to metabolic health. In contrast, Western-style and high-fat diets were associated with gut dysbiosis, inflammation, and negative epigenetic changes linked to metabolic disorders. Dietary interventions impacted DNA methylation, histone modifications, and microRNA expression, influencing long-term health.</p><p><strong>Conclusion: </strong>This review highlights the key role of diet-induced changes in the gut microbiome in modulating epigenetic mechanisms like DNA methylation and histone modifications. These alterations influence metabolic health, disease risk, and precision nutrition strategies. While dietary interventions show promise, challenges such as individual variability and methodological inconsistencies require further research to refine clinical applications of microbiome-driven nutrition.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"18 3","pages":"270-285"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12535778/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145336816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating the effects of using Tecar therapy with biofeedback compared to biofeedback alone in the treatment of fecal incontinence in children aged 4 to 16 years: a randomized clinical trial study. 一项随机临床试验研究:比较生物反馈与Tecar联合治疗4 - 16岁儿童大便失禁的疗效。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.22037/ghfbb.v18i1.3093
Azadeh Matlabi Lotfabadi, Fariba Ghaderi, Salman Nazary-Moghadam, Hamid Raza Kianifar, Parvin Sarbakhsh

Aim: Biofeedback has gained widespread recognition for its ability to facilitate and strengthen pelvic floor muscle function, making it a treatment of choice for these patients.

Background: Fecal incontinence is a common issue among children, particularly those with chronic constipation, significantly affecting both the child's and their family's quality of life. Effective therapeutic interventions are essential to mitigate the symptoms and improve overall well-being. Physiotherapy for pediatric fecal incontinence focuses on strengthening, enhancing endurance, and improving coordination of the anal sphincter and pelvic floor muscles.

Methods: This single-blind clinical trial examined the combined efficacy of Tecar therapy and biofeedback compared to biofeedback alone, with standard medical care serving as the control group. The study included 81 children diagnosed with fecal incontinence. Key outcomes evaluated were the severity of incontinence, severity of constipation, and frequency of incontinence episodes per week. These variables were evaluated before and after a six-week treatment period. Statistical analysis included repeated measures ANOVA for within-group comparisons and one-way ANOVA for between-group comparisons.

Results: The results indicated significant improvements across all measured variables in the intervention groups compared to the control group. Notably, the combination of Tecar therapy and biofeedback outperformed biofeedback alone in certain aspects, such as lowering the severity of incontinence.

Conclusion: The findings underscore physiotherapy as a non-invasive and effective first-line intervention for managing fecal incontinence and chronic constipation in pediatric populations. When feasible, the combination of Tecar therapy and biofeedback is recommended to achieve superior outcomes.

目的:生物反馈因其促进和加强骨盆底肌肉功能的能力而获得广泛认可,使其成为这些患者的治疗选择。背景:大便失禁是儿童的常见问题,特别是慢性便秘的儿童,严重影响儿童及其家庭的生活质量。有效的治疗干预对于减轻症状和改善整体健康至关重要。小儿大便失禁的物理治疗侧重于加强,增强耐力,改善肛门括约肌和骨盆底肌肉的协调。方法:本单盲临床试验以标准医疗护理为对照组,比较Tecar联合生物反馈治疗与单独生物反馈治疗的疗效。该研究包括81名被诊断为大便失禁的儿童。评估的主要结果是尿失禁的严重程度、便秘的严重程度和每周尿失禁发作的频率。在6周治疗前后对这些变量进行评估。统计分析包括组内比较的重复测量方差分析和组间比较的单向方差分析。结果:结果表明,与对照组相比,干预组的所有测量变量都有显著改善。值得注意的是,Tecar治疗和生物反馈的组合在某些方面优于单独的生物反馈,例如降低尿失禁的严重程度。结论:研究结果强调了物理治疗作为一种非侵入性和有效的一线干预措施来治疗儿科人群的大便失禁和慢性便秘。在可行的情况下,建议将Tecar治疗与生物反馈相结合,以获得更好的结果。
{"title":"Investigating the effects of using Tecar therapy with biofeedback compared to biofeedback alone in the treatment of fecal incontinence in children aged 4 to 16 years: a randomized clinical trial study.","authors":"Azadeh Matlabi Lotfabadi, Fariba Ghaderi, Salman Nazary-Moghadam, Hamid Raza Kianifar, Parvin Sarbakhsh","doi":"10.22037/ghfbb.v18i1.3093","DOIUrl":"10.22037/ghfbb.v18i1.3093","url":null,"abstract":"<p><strong>Aim: </strong>Biofeedback has gained widespread recognition for its ability to facilitate and strengthen pelvic floor muscle function, making it a treatment of choice for these patients.</p><p><strong>Background: </strong>Fecal incontinence is a common issue among children, particularly those with chronic constipation, significantly affecting both the child's and their family's quality of life. Effective therapeutic interventions are essential to mitigate the symptoms and improve overall well-being. Physiotherapy for pediatric fecal incontinence focuses on strengthening, enhancing endurance, and improving coordination of the anal sphincter and pelvic floor muscles.</p><p><strong>Methods: </strong>This single-blind clinical trial examined the combined efficacy of Tecar therapy and biofeedback compared to biofeedback alone, with standard medical care serving as the control group. The study included 81 children diagnosed with fecal incontinence. Key outcomes evaluated were the severity of incontinence, severity of constipation, and frequency of incontinence episodes per week. These variables were evaluated before and after a six-week treatment period. Statistical analysis included repeated measures ANOVA for within-group comparisons and one-way ANOVA for between-group comparisons.</p><p><strong>Results: </strong>The results indicated significant improvements across all measured variables in the intervention groups compared to the control group. Notably, the combination of Tecar therapy and biofeedback outperformed biofeedback alone in certain aspects, such as lowering the severity of incontinence.</p><p><strong>Conclusion: </strong>The findings underscore physiotherapy as a non-invasive and effective first-line intervention for managing fecal incontinence and chronic constipation in pediatric populations. When feasible, the combination of Tecar therapy and biofeedback is recommended to achieve superior outcomes.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"18 1","pages":"82-90"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12301541/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144741954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of viruses and molecular markers in the diagnosis and treatment of cancers and rare diseases: challenges and perspectives. 病毒和分子标记在癌症和罕见疾病的诊断和治疗中的作用:挑战和观点。
Q3 Medicine Pub Date : 2025-01-01 Epub Date: 2025-08-26 DOI: 10.22037/ghfbb.v18i3.3198
Amirhassan Rabbani, Nejat Mahdieh
{"title":"The role of viruses and molecular markers in the diagnosis and treatment of cancers and rare diseases: challenges and perspectives.","authors":"Amirhassan Rabbani, Nejat Mahdieh","doi":"10.22037/ghfbb.v18i3.3198","DOIUrl":"10.22037/ghfbb.v18i3.3198","url":null,"abstract":"","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"18 3","pages":"260-263"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12535776/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145336778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the effectiveness of citation count as a measure of methodological quality in esophagogastric surgery research: a comparative analysis with the MINORS score and levels of evidence. 评估引用次数作为衡量食管胃手术研究方法质量的有效性:与 MINORS 评分和证据等级的比较分析。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.22037/ghfbb.v17i3.3005
Suhaib Js Ahmad, Ahmed R Ahmed, Ata Mohajer-Bastami, Sarah Moin, Benedict Sweetman, Sjaak Pouwels, Marion Head, Joseph Borucki, Anil Lala, Wah Yang, Christopher John Houlden, Tarek Garsaa, Aristomenis Exadaktylos

Aim: The primary objective was to assess the relationship between the citation number and the quality of the articles, as compared with the level of evidence and the MINORS score. This study's secondary objective was to characterize the 50 most cited articles in the field of oesophagectomy research.

Background: There has been an increased need for an evaluation tool to indicate research quality. Available quality assessment tools include the Level of Evidence, the MINORS score, the Cochrane Risk of Bias 2.0 Tool, the Newcastle Ottawa Scale, CASP Appraisal Checklists, and Legend Evidence Evaluation tools.

Methods: The Web of Science allowed evaluating and comparing articles on oesophagectomy research. The quality of the 50 most cited articles was assessed using the Oxford Centre level of evidence classification and the methodological index for non-randomized studies (MINORS).

Results: Level of evidence II studies were cited more than level IV (P=0.008). There was a significant positive correlation between citation number and MINORS score (P=0.002). The median MINORS score was highest amongst level II studies, followed by levels III, IV, and I. The median MINORS score for level II evidence was significantly higher than for level IV (P=0.001). The study sample size is associated with higher levels of evidence but does not correlate with the citation number. Female authors contributed to 4 out of 50 articles. Recently published articles tended to be cited more frequently. More authors equated to more citations. Prospective studies are more likely to be cited.

Conclusion: Citation analysis can be used as an indicator of quality when assessing articles. It should, however, be used with caution as highly cited work, famous authors, and journals are all more likely to be cited. Citation analysis should be used alongside other well-established tools.

目的:本研究的主要目的是评估文章的引用次数与质量之间的关系,并与证据级别和 MINORS 评分进行比较。本研究的次要目标是描述食道切除术研究领域被引用次数最多的 50 篇文章的特点:背景:人们越来越需要一种评估工具来说明研究质量。现有的质量评估工具包括证据等级、MINORS评分、Cochrane偏倚风险2.0工具、纽卡斯尔渥太华量表、CASP评估清单和Legend证据评估工具:通过科学网可对有关食道切除术研究的文章进行评估和比较。采用牛津中心证据等级分类和非随机研究方法指数(MINORS)评估了被引用最多的50篇文章的质量:结果:证据等级为二级的研究被引用的次数多于四级(P=0.008)。引用次数与 MINORS 分数之间存在明显的正相关(P=0.002)。二级研究的 MINORS 中位数得分最高,其次是三级、四级和一级。研究样本量与较高的证据等级相关,但与引用次数无关。在 50 篇文章中,有 4 篇文章的作者为女性。新近发表的文章往往被更频繁地引用。作者越多,引用次数越多。前瞻性研究更容易被引用:引用分析可作为评估文章质量的指标。结论:在评估文章时,引文分析可用作质量指标,但应谨慎使用,因为高被引作品、著名作者和期刊都更有可能被引用。引文分析应与其他成熟的工具一起使用。
{"title":"Evaluating the effectiveness of citation count as a measure of methodological quality in esophagogastric surgery research: a comparative analysis with the MINORS score and levels of evidence.","authors":"Suhaib Js Ahmad, Ahmed R Ahmed, Ata Mohajer-Bastami, Sarah Moin, Benedict Sweetman, Sjaak Pouwels, Marion Head, Joseph Borucki, Anil Lala, Wah Yang, Christopher John Houlden, Tarek Garsaa, Aristomenis Exadaktylos","doi":"10.22037/ghfbb.v17i3.3005","DOIUrl":"10.22037/ghfbb.v17i3.3005","url":null,"abstract":"<p><strong>Aim: </strong>The primary objective was to assess the relationship between the citation number and the quality of the articles, as compared with the level of evidence and the MINORS score. This study's secondary objective was to characterize the 50 most cited articles in the field of oesophagectomy research.</p><p><strong>Background: </strong>There has been an increased need for an evaluation tool to indicate research quality. Available quality assessment tools include the Level of Evidence, the MINORS score, the Cochrane Risk of Bias 2.0 Tool, the Newcastle Ottawa Scale, CASP Appraisal Checklists, and Legend Evidence Evaluation tools.</p><p><strong>Methods: </strong>The Web of Science allowed evaluating and comparing articles on oesophagectomy research. The quality of the 50 most cited articles was assessed using the Oxford Centre level of evidence classification and the methodological index for non-randomized studies (MINORS).</p><p><strong>Results: </strong>Level of evidence II studies were cited more than level IV (P=0.008). There was a significant positive correlation between citation number and MINORS score (P=0.002). The median MINORS score was highest amongst level II studies, followed by levels III, IV, and I. The median MINORS score for level II evidence was significantly higher than for level IV (P=0.001). The study sample size is associated with higher levels of evidence but does not correlate with the citation number. Female authors contributed to 4 out of 50 articles. Recently published articles tended to be cited more frequently. More authors equated to more citations. Prospective studies are more likely to be cited.</p><p><strong>Conclusion: </strong>Citation analysis can be used as an indicator of quality when assessing articles. It should, however, be used with caution as highly cited work, famous authors, and journals are all more likely to be cited. Citation analysis should be used alongside other well-established tools.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"17 3","pages":"212-224"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11413383/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142284283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Translation, cultural adaptation, reliability, and validity of the Persian version of the Constipation Severity Instrument. 波斯语版便秘严重程度量表的翻译、文化适应性、可靠性和有效性。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.22037/ghfbb.v17i2.2867
Zeinab Moradi, Farhad Azadi, Jalil Shoa Hasani, Mohsen Vahedi

Aim: The aim of this study was to translate and cross-culturally adapt the Constipation Severity Instrument (CSI) and assess its reliability and validity in the Iranian Persian language with chronic functional constipation.

Background: Chronic functional constipation is a common complaint characterized by a range of symptoms. The use of a validated tool adapted to the culture is an important part of the treatment process.

Methods: CSI was translated into Persian language according to Beaton's guidelines. One hundred and twenty-five patients with chronic functional constipation, according to ROME IV criteria, completed the questionnaires. Face validity was assessed in two qualitative and quantitative forms (impact score), internal consistency and test-retest reliability were assessed by Cronbach's alpha coefficient and intraclass correlation coefficient (ICC), respectively. Convergent validity was assessed by correlating the total scores of the CSI and the WCSS. The floor/ ceiling effects of the questionnaire were also assessed.

Results: The impact score of all questions was greater than 1.5. The Cronbach's alpha coefficient for the total score was 0.90 and the ICC was 0.90. The total score of the CSI was significantly correlated with the total score of the WCSS (Spearman's p=0.74). No floor/ceiling effects were found.

Conclusion: The Persian version of the CSI is a reliable and valid tool that can be used for psychometric evaluation. Clinicians can also benefit from this questionnaire when assessing treatment outcomes in Iranian patients.

目的:本研究旨在翻译便秘严重程度量表(CSI)并对其进行跨文化调整,评估其在伊朗波斯语慢性功能性便秘患者中的信度和效度:背景:慢性功能性便秘是一种常见病,具有一系列症状。使用适合当地文化的有效工具是治疗过程的重要组成部分:方法:根据比顿指南将 CSI 翻译成波斯语。根据 ROME IV 标准,125 名慢性功能性便秘患者完成了问卷调查。通过定性和定量(影响得分)两种形式评估了问卷的正面效度,并分别通过克朗巴赫α系数和类内相关系数(ICC)评估了内部一致性和测试-再测可靠性。通过对 CSI 和 WCSS 的总分进行相关性分析,评估了统合效度。此外,还对问卷的下限/上限效应进行了评估:所有问题的影响得分均大于 1.5。总分的 Cronbach's alpha 系数为 0.90,ICC 为 0.90。CSI 总分与 WCSS 总分呈显著相关(Spearman's p=0.74)。没有发现地板/天花板效应:结论:波斯语版 CSI 是一种可靠有效的工具,可用于心理测量学评估。临床医生在评估伊朗患者的治疗效果时也可从该问卷中获益。
{"title":"Translation, cultural adaptation, reliability, and validity of the Persian version of the Constipation Severity Instrument.","authors":"Zeinab Moradi, Farhad Azadi, Jalil Shoa Hasani, Mohsen Vahedi","doi":"10.22037/ghfbb.v17i2.2867","DOIUrl":"10.22037/ghfbb.v17i2.2867","url":null,"abstract":"<p><strong>Aim: </strong>The aim of this study was to translate and cross-culturally adapt the Constipation Severity Instrument (CSI) and assess its reliability and validity in the Iranian Persian language with chronic functional constipation.</p><p><strong>Background: </strong>Chronic functional constipation is a common complaint characterized by a range of symptoms. The use of a validated tool adapted to the culture is an important part of the treatment process.</p><p><strong>Methods: </strong>CSI was translated into Persian language according to Beaton's guidelines. One hundred and twenty-five patients with chronic functional constipation, according to ROME IV criteria, completed the questionnaires. Face validity was assessed in two qualitative and quantitative forms (impact score), internal consistency and test-retest reliability were assessed by Cronbach's alpha coefficient and intraclass correlation coefficient (ICC), respectively. Convergent validity was assessed by correlating the total scores of the CSI and the WCSS. The floor/ ceiling effects of the questionnaire were also assessed.</p><p><strong>Results: </strong>The impact score of all questions was greater than 1.5. The Cronbach's alpha coefficient for the total score was 0.90 and the ICC was 0.90. The total score of the CSI was significantly correlated with the total score of the WCSS (Spearman's p=0.74). No floor/ceiling effects were found.</p><p><strong>Conclusion: </strong>The Persian version of the CSI is a reliable and valid tool that can be used for psychometric evaluation. Clinicians can also benefit from this questionnaire when assessing treatment outcomes in Iranian patients.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"17 2","pages":"198-205"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11234489/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141590136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of oral Midodrine in preventing hepatorenal syndrome in Child-Turcotte-Pugh class C cirrhotics: a pilot study. 口服米多卡因预防child - turcote - pugh C级肝硬化肝肾综合征的作用:一项初步研究。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.22037/ghfbb.v17i4.3019
Tariq Salim, Dadasaheb Maindad

Aim: The purpose of the study was to assess benefits of oral midodrine in the role of primary prevention of hepatorenal syndrome (HRS) in Child-Turcotte-Pugh Class C (CTP-C) cirrhotics.

Background: The present non-randomized pilot study was designed for primary prevention of HRS as there is absence of an effective and definite treatment for this complication of cirrhosis to date other than liver transplant (LT).

Methods: This study effectively involved 30 patients each enrolled in interventional and control arms suffering from liver cirrhosis CTP-C with normal renal function and having a mean arterial pressure (MAP) < 80 mmHg who were subjected to clinical examination and baseline blood investigations. The mean daily dosage of midodrine used across the study group was 16.75 mg.

Results: At the end of 4 months of study, 11 individuals completed the study without attaining any endpoints from the control group while 23 accomplished it from the interventional arm. Nearly 50 % patients required a midodrine dose of 7.5 mg 8th hourly while the rest attained the targeted MAP with lower doses. By increasing MAP, the rate of HRS development during the study period (i.e. 4 months) was found to be significantly reduced in patients from interventional arm. The number needed to treat (NNT) observed in survival analysis to prevent one death was found to be 7.6.

Conclusion: This study successfully established the role oral midodrine in primary prevention of HRS in cirrhotics at high risk. Midodrine was well tolerated with no significant adverse effects in patients under study.

目的:本研究的目的是评估口服midodrine在child - turcote - pugh C级(CTP-C)肝硬化肝肾综合征(HRS)一级预防中的益处。背景:目前的非随机试点研究是为HRS的一级预防而设计的,因为迄今为止除了肝移植(LT)之外,尚无有效和明确的治疗方法来治疗这种肝硬化并发症。方法:本研究有效纳入干预组和对照组各30例肝硬化CTP-C患者,均为肾功能正常、平均动脉压(MAP) < 80 mmHg的患者,接受临床检查和基线血液调查。整个研究组使用的米多宁平均每日剂量为16.75 mg。结果:在4个月的研究结束时,11人完成了研究,没有从对照组获得任何终点,而23人从干预组完成了研究。近50%的患者需要每小时7.5 mg的midodrine剂量,而其余患者使用较低剂量即可达到目标MAP。通过增加MAP,我们发现介入组患者在研究期间(即4个月)HRS的发生率显著降低。生存分析中观察到的预防1例死亡所需治疗数(NNT)为7.6。结论:本研究成功确立了口服midodrine在肝硬化高危人群HRS一级预防中的作用。在接受研究的患者中,Midodrine耐受性良好,没有明显的不良反应。
{"title":"Role of oral Midodrine in preventing hepatorenal syndrome in Child-Turcotte-Pugh class C cirrhotics: a pilot study.","authors":"Tariq Salim, Dadasaheb Maindad","doi":"10.22037/ghfbb.v17i4.3019","DOIUrl":"10.22037/ghfbb.v17i4.3019","url":null,"abstract":"<p><strong>Aim: </strong>The purpose of the study was to assess benefits of oral midodrine in the role of primary prevention of hepatorenal syndrome (HRS) in Child-Turcotte-Pugh Class C (CTP-C) cirrhotics.</p><p><strong>Background: </strong>The present non-randomized pilot study was designed for primary prevention of HRS as there is absence of an effective and definite treatment for this complication of cirrhosis to date other than liver transplant (LT).</p><p><strong>Methods: </strong>This study effectively involved 30 patients each enrolled in interventional and control arms suffering from liver cirrhosis CTP-C with normal renal function and having a mean arterial pressure (MAP) < 80 mmHg who were subjected to clinical examination and baseline blood investigations. The mean daily dosage of midodrine used across the study group was 16.75 mg.</p><p><strong>Results: </strong>At the end of 4 months of study, 11 individuals completed the study without attaining any endpoints from the control group while 23 accomplished it from the interventional arm. Nearly 50 % patients required a midodrine dose of 7.5 mg 8th hourly while the rest attained the targeted MAP with lower doses. By increasing MAP, the rate of HRS development during the study period (i.e. 4 months) was found to be significantly reduced in patients from interventional arm. The number needed to treat (NNT) observed in survival analysis to prevent one death was found to be 7.6.</p><p><strong>Conclusion: </strong>This study successfully established the role oral midodrine in primary prevention of HRS in cirrhotics at high risk. Midodrine was well tolerated with no significant adverse effects in patients under study.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"17 4","pages":"438-449"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12094511/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144127194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting the NCAPD3 gene activates EGFR and ASNS as two pivotal contributors to gastric cancer progression. 靶向NCAPD3基因激活EGFR和ASNS作为胃癌进展的两个关键因素。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.22037/ghfbb.v17i4.3031
Fatemeh Bandarian, Farideh Razi, Somayeh Jahani-Sharafat, Mohammad Rostami Nejad, Babak Arjmand, Masoumeh Farahani

Aim: This study was conducted to discover the effect of NCAPD3 knockdown on the gene expression profile of gastric cancer.

Background: Gastric cancer, a potentially fatal disease, requires thorough evaluation for targeted interventions. Through the post-analysis of microarray data, it is crucial to further examine the impact of NCAPD3 (Non-SMC condensin II complex subunit D3) inhibition in gastric cancer, emphasizing the need for a more comprehensive analysis of this knockdown.

Methods: The use of Cytoscape and its plug-ins for protein-protein interaction network analysis enables the identification of genes that significantly affect network stability. These hub-bottlenecks are regulated due to the NCAPD3 inhibition and some of them act as compensators in this condition. The hub-bottlenecks pathways identified by ClueGO indicate their relationships in underlying mechanisms of knockdown. These identified central differentially expressed genes could be considered eligible targets for therapeutic interventions. Some of them play compensative roles while others are regulated in NCAPD3 knockdown.

Results: It can be concluded that some of the hub-bottlenecks contribute to compensation mechanisms including NPM1, PTEN, EGFR, HSPA5, and ASNS, while the other ones including HSPA4, DHX9, CAV1, MAP1LC3B, and SRSF1 are among the regulated genes.

Conclusion: In particular, the up-regulation of EGFR and ASNS genes in the knockdown scenario could significantly impact and deteriorate cancer treatment outcomes after comprehensive validation studies.

目的:探讨NCAPD3基因下调对胃癌基因表达谱的影响。背景:胃癌是一种潜在的致命疾病,需要对有针对性的干预进行彻底的评估。通过微阵列数据的后分析,进一步研究NCAPD3 (Non-SMC凝缩素II复合物亚单位D3)抑制在胃癌中的影响至关重要,强调需要对这种敲低进行更全面的分析。方法:利用Cytoscape及其插件进行蛋白-蛋白相互作用网络分析,鉴定出显著影响网络稳定性的基因。由于NCAPD3抑制,这些中枢瓶颈受到调节,其中一些在这种情况下充当补偿器。ClueGO发现的中心-瓶颈通路表明它们在敲低的潜在机制中的关系。这些确定的中心差异表达基因可以被认为是治疗干预的合格靶点。其中一些在NCAPD3敲低中起补偿性作用,而另一些在NCAPD3敲低中受调节。结果:NPM1、PTEN、EGFR、HSPA5、ASNS等枢纽瓶颈参与了补偿机制,HSPA4、DHX9、CAV1、MAP1LC3B、SRSF1等枢纽瓶颈参与了补偿机制的调控。结论:经过综合验证研究,EGFR和ASNS基因在基因敲低情况下的上调可显著影响和恶化癌症治疗结果。
{"title":"Targeting the NCAPD3 gene activates EGFR and ASNS as two pivotal contributors to gastric cancer progression.","authors":"Fatemeh Bandarian, Farideh Razi, Somayeh Jahani-Sharafat, Mohammad Rostami Nejad, Babak Arjmand, Masoumeh Farahani","doi":"10.22037/ghfbb.v17i4.3031","DOIUrl":"10.22037/ghfbb.v17i4.3031","url":null,"abstract":"<p><strong>Aim: </strong>This study was conducted to discover the effect of NCAPD3 knockdown on the gene expression profile of gastric cancer.</p><p><strong>Background: </strong>Gastric cancer, a potentially fatal disease, requires thorough evaluation for targeted interventions. Through the post-analysis of microarray data, it is crucial to further examine the impact of NCAPD3 (Non-SMC condensin II complex subunit D3) inhibition in gastric cancer, emphasizing the need for a more comprehensive analysis of this knockdown.</p><p><strong>Methods: </strong>The use of Cytoscape and its plug-ins for protein-protein interaction network analysis enables the identification of genes that significantly affect network stability. These hub-bottlenecks are regulated due to the NCAPD3 inhibition and some of them act as compensators in this condition. The hub-bottlenecks pathways identified by ClueGO indicate their relationships in underlying mechanisms of knockdown. These identified central differentially expressed genes could be considered eligible targets for therapeutic interventions. Some of them play compensative roles while others are regulated in NCAPD3 knockdown.</p><p><strong>Results: </strong>It can be concluded that some of the hub-bottlenecks contribute to compensation mechanisms including NPM1, PTEN, EGFR, HSPA5, and ASNS, while the other ones including HSPA4, DHX9, CAV1, MAP1LC3B, and SRSF1 are among the regulated genes.</p><p><strong>Conclusion: </strong>In particular, the up-regulation of EGFR and ASNS genes in the knockdown scenario could significantly impact and deteriorate cancer treatment outcomes after comprehensive validation studies.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"17 4","pages":"400-408"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12094513/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144127196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Gastroenterology and Hepatology From Bed to Bench
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1